Effect of Thoracic Paravertebral Block on Chronic Pain and Cognitive Function After Thoracoscopic Partial Pulmonary Resection in Elderly Patients

Sponsor
The First Hospital of Qinhuangdao (Other)
Overall Status
Recruiting
CT.gov ID
NCT05364216
Collaborator
(none)
100
1
3
8.6
11.6

Study Details

Study Description

Brief Summary

To investigate the effect of ultrasound-guided thoracic paravertebral nerve block on postoperative acute and chronic pain and cognitive function in elderly patients with thoracoscopic partial lung resection.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Measurement of cognitive function
  • Procedure: Thoracic paravertebral block
  • Behavioral: The assessment of cognitive function
N/A

Detailed Description

A total of 100 patients who were admitted to Qinhuangdao First Hospital for and divided into control group (group C ), thoracic paravertebral nerve block combined with general anesthesia group (group T).

Group C received general anesthesia, and group T received 0.375% ropivacaine 20 ml of thoracic paravertebral nerve block combined with general anesthesia after induction of anesthesia. SBP(Systolic Blood Pressure)/DP (Diastolic Pressure)and HR(Heart Rate) of the two groups were recorded before anesthesia induction (T1), at the time of intubation (T2), at the beginning of surgery (T5), immediately after surgery (T6), and five minutes after extubation (T7) . rScO2(Regional cerebral oxygen saturation) was recorded in both groups at (T1), five minutes after induction(T3), five minutes after single lung ventilation on lateral recumbent(T4), (T6), (T7). The incidence of acute and chronic pain after surgery was compared between the two groups by VAS(Visual analogue scale)after extubation , one day after surgery, and three months after surgery.

The cognitive function of the two groups was assessed with the Mini Mental State Scale (MMSE) and the Montreal Cognitive Assessment Scale (MoCA-Beijing) on the day before , one day after and three months after surgery, comparing the incidence of POD (postoperative cognitive dysfunction) between the two groups.Analyze whether paravertebral block can reduce the incidence of POD by improving brain oxygen saturation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Prevention
Official Title:
Effect of Thoracic Paravertebral Block on Chronic Pain and Cognitive Function After Thoracoscopic Partial Pulmonary Resection in Elderly Patients
Actual Study Start Date :
Apr 12, 2022
Anticipated Primary Completion Date :
Sep 30, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Group C

The general anesthesia was used.In this group, cognitive function was evaluated by MMSE and MoCA scale on one day before surgery, one day after surgery, and three months after surgery. Acute postoperative pain was was evaluated by VAS after extubation , one day after surgery, Chronic postsurgical pain was evaluated by VAS on three months after surgery.

Behavioral: Measurement of cognitive function
Patients undergoing thoracoscopic surgery underwent general anesthesia.MMSE and MoCA were assessed at one day before surgery, one day after surgery, and three months after surgery
Other Names:
  • assessment of POD
  • Experimental: Group T

    Group T received 0.375% ropivacaine 20ml thoracic paravertebral nerve block combined with general anesthesia under ultrasound guidance after anesthesia induction.

    Behavioral: Measurement of cognitive function
    Patients undergoing thoracoscopic surgery underwent general anesthesia.MMSE and MoCA were assessed at one day before surgery, one day after surgery, and three months after surgery
    Other Names:
  • assessment of POD
  • Procedure: Thoracic paravertebral block
    The patient was placed in lateral supine position, and the T5 spinous process was moved 2 to 3 cm laterally to the operative side as the puncture point, and the pleura and T5 transverse process were observed, and the paraspinal space was observed on the lower lateral side of the transverse process. Using in-plane technique, the needle position was adjusted under ultrasound visualization to reach the paraspinal space. 20ml 0.375% ropivacaine was injected into the suction syringe when there was no blood or gas, and the drug liquid could be seen spreading outside the pleura. "Landscape sign" appeared, indicating successful block
    Other Names:
  • General anesthesia
  • Other: Non-surgical controls

    Age and sex-matched community people are included for three sessions of MMSE test evaluation for calculation of POD incidence as normal control to in Z value calculation of POD incidence to rule out learning effect.

    Behavioral: The assessment of cognitive function
    Participants were assessed for MMSE and MoCA at the same period as the group C

    Outcome Measures

    Primary Outcome Measures

    1. Incidence of POD at one day after surgery [One day after surgery]

      The MMSE and MoCA difference between the patients on the day before surgery and one day after surgery was compared and substituted into the formula.The formula of Z-scoring method is Z= (XC-X) /SDXC, where X refers to the change value of patients' MMSE/MoCA score at one day before surgery and one day after surgery. XC is the mean change value of the non-surgical control group at the same time, and SDXC is the standard deviation of the change value of the non-surgical control group. Finally, the Z-value at one day after surgery is calculated respectively. If the value of Z is ≥1.96, the patient is considered to have developed POCD

    2. Incidence of POD at three months after surgery [Three months after surgery]

      The MMSE and MoCA difference between the patients on the day before surgery and three months after surgery was compared and substituted into the formula.The formula of Z-scoring method is Z= (XC-X) /SDXC, where X refers to the change value of patients' MMSE score at one day before surgery and three months after surgery. XC is the mean change value of the non-surgical control group at the same time, and SDXC is the standard deviation of the change value of the non-surgical control group. Finally, the Z-value at three months after surgery is calculated respectively. If the value of Z is ≥1.96, the patient is considered to have developed POCD

    3. Change in pain assessed by Visual Analogue Scale [Five minutes after extubation]

      Divide the ruler into 10 equal parts, with 0 means no pain, 1-3 indicating mild pain, 4-6 indicating moderate pain(Patients have mild restrictions on daily activities or mild sleep disturbances due to pain,maybe require additional analgesic treatment), and 7-10 indicating severe pain(Patients are unable to fall asleep and cannot perform daily activities,they strongly request the use of analgesics).

    4. Change in pain assessed by Visual Analogue Scale [One day after surgery]

      Divide the ruler into 10 equal parts, with 0 means no pain, 1-3 indicating mild pain, 4-6 indicating moderate pain(Patients have mild restrictions on daily activities or mild sleep disturbances due to pain,maybe require additional analgesic treatment), and 7-10 indicating severe pain(Patients are unable to fall asleep and cannot perform daily activities,they strongly request the use of analgesics).

    5. Change in pain assessed by Visual Analogue Scale [Three months after surgery]

      Divide the ruler into 10 equal parts, with 0 means no pain, 1-3 indicating mild pain, 4-6 indicating moderate pain(Patients have mild restrictions on daily activities or mild sleep disturbances due to pain,maybe require additional analgesic treatment), and 7-10 indicating severe pain(Patients are unable to fall asleep and cannot perform daily activities,they strongly request the use of analgesics).

    Secondary Outcome Measures

    1. The change of SBP/DP [before anesthesia induction , at the time of intubation , at the beginning of surgery , immediately after surgery , and five minutes after extubation]

      The change of Systolic blood pressure(SBP) and Diastolic pressure(DP) among the two groups

    2. The change of HR [before anesthesia induction , at the time of intubation , at the beginning of surgery , immediately after surgery , and five minutes after extubation]

      The change of Heart rate(HR) among the two groups

    3. The change of rScO2, maximum and minimum of rScO2, duration of 10% below the base value [before anesthesia induction , five minutes after induction, five minutes after single lung ventilation on lateral recumbent, immediately after surgery, and five minutes after extubation]

      The change of regional cerebral oxygen saturation(rScO2), maximum and minimum of rScO2, duration of 10% below the base value among the two groups

    4. Anesthetic drug [during the surgery]

      The dosage of remifentanil and propofol in different groups were recorded

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • BMI less than 30 kg/m2

    • American Society of Anesthesiologists (ASA) grades I-III

    • The score of Mini Mental state examination≥24

    • The score of Montreal Cognitive Assessment-Beijing Scale≥26

    Exclusion Criteria:
    • Patients with heart, lung, brain and other vital organ disorders

    • The score of Mini Mental state examination≤23

    • The score of Montreal Cognitive Assessment-Beijing Scale≤25

    • Preoperative psychiatric disorders or long-term use of drugs affecting the psychiatric system

    • Have severe visual, hearing, speech impairment or other inability to communicate with the visitor

    • Have contraindications to thoracic parathymic block

    • Refuse to sign informed consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The First hosptial of Qinhuangdao Qinhuangdao Hebei China 066000

    Sponsors and Collaborators

    • The First Hospital of Qinhuangdao

    Investigators

    • Study Director: Qinshuang Liu, master, The First hosptial of Qinhuangdao
    • Study Chair: Linyu Shi, master, The First hosptial of Qinhuangdao

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    The First Hospital of Qinhuangdao
    ClinicalTrials.gov Identifier:
    NCT05364216
    Other Study ID Numbers:
    • 20220503
    First Posted:
    May 6, 2022
    Last Update Posted:
    May 6, 2022
    Last Verified:
    May 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by The First Hospital of Qinhuangdao
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 6, 2022